You are here: Home » Companies » Results
Business Standard

Wockhardt reports net profit at Rs 760 cr for June qtr on exceptional items

The company had posted a net loss of Rs 36.88 crore for April-June 2019-20, Wockhardt said in a filing to BSE

Topics
Wockhardt | Q1 results | Dr Reddy's Laboratories

Press Trust of India  |  New Delhi 

Wockhardt
Total income stood at Rs 606.22 crore in the quarter under review. It was Rs 733.66 crore in the year-ago period, the filing added.

Drug firm on Saturday reported a consolidated net profit of Rs 759.75 crore for June quarter mainly on account of exceptionalitems in connection with the transfer of a business comprising 62 products and Baddi facility toDr Reddy's Laboratories.

The company had posted a net loss of Rs 36.88 crore for April-June 2019-20, said in a filing to BSE.

Total income stood at Rs 606.22 crore in the quarter under review. It was Rs 733.66 crore in the year-ago period, the filing added.

launchednew chemical entity (NCE) during the quarterin the Indian pharma market. Products have been launched under the tablet and injection category under the brand name 'Emrock O and Emrock', the filing said.

The focus on strategic R&D initiatives of the company in the global arena continued to remain one of the key priorities,itadded.

It said that divestment of business undertaking to Dr Reddy's Laboratories was accomplished during the quarter and Rs 1,483 crore has been received towards the same.

"Rs 43 crore out of Rs 67 crore deposited by the purchaser in an escrow account, towards adjustments for, inter alia, net working capital, employee liabilities and certain other contractual and statutory liabilities etc has since been settled and received," it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, August 29 2020. 17:51 IST
RECOMMENDED FOR YOU
.